The methyl binding domain containing protein MBD5 is a transcriptional regulator responsible for 2q23.1 deletion syndrome

References

• Jaillard S, Dubourg C, Gerard-Blanluet M, Delahaye A, Pasquier L, Dupont C, Henry C, Tabet AC, Lucas J, Aboura A, et al. 2q23.1 microdeletion identified by array comparative genomic hybridisation: An emerging phenotype with angelman-like features? J Med Genet 2009; 46:847-55; PMID:18812405; http://dx.doi.org/10.1136/jmg.2008.058156
   PubMed Web of Science ®Google Scholar
• van Bon BW, Koolen DA, Brueton L, McMullan D, Lichtenbelt KD, Ades LC, Peters G, Gibson K, Moloney S, Novara F, et al. The 2q23.1 microdeletion syndrome: Clinical and behavioural phenotype. Eur J Hum Genet 2010; 18:163-70; PMID:19809484; http://dx.doi.org/10.1038/ejhg.2009.152
   PubMed Web of Science ®Google Scholar
• Talkowski ME, Mullegama SV, Rosenfeld JA, van Bon BW, Shen Y, Repnikova EA, Gastier-Foster J, Thrush DL, Kathiresan S, Ruderfer DM, et al. Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder. Am J Hum Genet 2011; 89:551-63; PMID:21981781; http://dx.doi.org/10.1016/j.ajhg.2011.09.011
   PubMed Web of Science ®Google Scholar
• Chung BH, Stavropoulos J, Marshall CR, Weksberg R, Scherer SW, Yoon G. 2q23 de novo microdeletion involving the MBD5 gene in a patient with developmental delay, postnatal microcephaly and distinct facial features. Am J Med Genet A 2011; 155A:424-9; PMID:21271666; http://dx.doi.org/10.1002/ajmg.a.33821
   PubMed Web of Science ®Google Scholar
• Bonnet C, Ali Khan A, Bresso E, Vigouroux C, Beri M, Lejczak S, Deemer B, Andrieux J, Philippe C, Moncla A, et al. Extended spectrum of MBD5 mutations in neurodevelopmental disorders. Eur J Hum Genet 2013; 21:1457-61; PMID:23422940; http://dx.doi.org/10.1038/ejhg.2013.22
   PubMed Web of Science ®Google Scholar
• Mullegama SV, Rosenfeld JA, Orellana C, van Bon BW, Halbach S, Repnikova EA, Brick L, Li C, Dupuis L, Rosello M, et al. Reciprocal deletion and duplication at 2q23.1 indicates a role for MBD5 in autism spectrum disorder. Eur J Hum Genet 2014; 22:57-63; PMID:23632792; http://dx.doi.org/10.1038/ejhg.2013.67
   PubMed Web of Science ®Google Scholar
• Jaenisch R, Bird A. Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals. Nat Genet 2003; 33 Suppl:245-54; PMID:12610534; http://dx.doi.org/10.1038/ng1089
   PubMed Web of Science ®Google Scholar
• Bestor TH, Bourc'his D. Transposon silencing and imprint establishment in mammalian germ cells. Cold Spring Harb Symp Quant Biol 2004; 69:381-7; PMID:16117671; http://dx.doi.org/10.1101/sqb.2004.69.381
   PubMedGoogle Scholar
• Roloff TC, Ropers HH, Nuber UA. Comparative study of methyl-CpG-binding domain proteins. BMC Genomics 2003; 4:1; PMID:12529184
   PubMed Web of Science ®Google Scholar
• Laget S, Joulie M, Le Masson F, Sasai N, Christians E, Pradhan S, Roberts RJ, Defossez PA. The human proteins MBD5 and MBD6 associate with heterochromatin but they do not bind methylated DNA. PLoS One 2010; 5:e11982; PMID:20700456; http://dx.doi.org/10.1371/journal.pone.0011982
   PubMed Web of Science ®Google Scholar
• Hendrich B, Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 1998; 18:6538-47.
   PubMed Web of Science ®Google Scholar
• Laguri C, Duband-Goulet I, Friedrich N, Axt M, Belin P, Callebaut I, Gilquin B, Zinn-Justin S, Couprie J. Human mismatch repair protein MSH6 contains a PWWP domain that targets double stranded DNA. Biochemistry 2008; 47:6199-207; PMID:18484749; http://dx.doi.org/10.1021/bi7024639
   PubMed Web of Science ®Google Scholar
• Vermeulen M, Eberl HC, Matarese F, Marks H, Denissov S, Butter F, Lee KK, Olsen JV, Hyman AA, Stunnenberg HG, et al. Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers. Cell 2010; 142:967-80; PMID:20850016; http://dx.doi.org/10.1016/j.cell.2010.08.020
   PubMed Web of Science ®Google Scholar
• Tao Y, Wu Q, Guo X, Zhang Z, Shen Y, Wang F. MBD5 regulates iron metabolism via methylation-independent genomic targeting of Fth1 through KAT2A in mice. Br J Haematol 2014; 166:279-91; PMID:24750026; http://dx.doi.org/10.1111/bjh.12863
   PubMed Web of Science ®Google Scholar
• Camarena V, Cao L, Abad C, Abrams A, Toledo Y, Araki K, Araki M, Walz K, Young JI. Disruption of Mbd5 in mice causes neuronal functional deficits and neurobehavioral abnormalities consistent with 2q23.1 microdeletion syndrome. EMBO Mol Med 2014; 6:1003-15; PMID:25001218; http://dx.doi.org/10.15252/emmm.201404044
   PubMed Web of Science ®Google Scholar
• Du Y, Liu B, Guo F, Xu G, Ding Y, Liu Y, Sun X, Xu G. The essential role of Mbd5 in the regulation of somatic growth and glucose homeostasis in mice. PLoS One 2012; 7:e47358; PMID:23077600; http://dx.doi.org/10.1371/journal.pone.0047358
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), Text Revision. Washington, D.C: American Psychiatric Press, Inc, 2000.
   Google Scholar
• Noh GJ, Graham JM,Jr. 2q23.1 microdeletion of the MBD5 gene in a female with seizures, developmental delay and distinct dysmorphic features. Eur J Med Genet 2012; 55:354-7; PMID:22659271; http://dx.doi.org/10.1016/j.ejmg.2012.05.003
   PubMed Web of Science ®Google Scholar
• Williams SR, Mullegama SV, Rosenfeld JA, Dagli AI, Hatchwell E, Allen WP, Williams CA, Elsea SH. Haploinsufficiency of MBD5 associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and seizures. Eur J Hum Genet 2010; 18:436-41; PMID:19904302; http://dx.doi.org/10.1038/ejhg.2009.199
   PubMed Web of Science ®Google Scholar